Dr. Charles Dudley Graham, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 2910 Tricom St, North Charleston, SC 29406 Phone: 843-572-9211 Fax: 843-572-0457 |
Dr. Ashley Abide Jeter, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2910 Tricom St, North Charleston, SC 29406 Phone: 843-572-9211 Fax: 843-572-0458 |
Dr. Charles Stephen Holladay, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2910 Tricom St, Charleston Cancer Center, North Charleston, SC 29406 Phone: 843-572-9211 Fax: 843-572-0457 |
Dr. Margaret Stafford Brady, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 8950 University Blvd Ste 100, North Charleston, SC 29406 Phone: 843-797-3555 Fax: 843-797-2523 |
Dr. Julia Hay Saylors, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2910 Tricom St, North Charleston, SC 29406 Phone: 843-572-9211 |
Dr. Douglas L Michaelsen, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2910 Tricom St, Charleston Cancer Center, North Charleston, SC 29406 Phone: 843-572-9211 |
News Archive
Agenus Inc., a biotechnology company developing novel immune system activating treatments for cancers and infectious diseases, announced that Phase 2 results of Prophage G-200 vaccine in recurrent patients with glioblastoma multiforme were hailed as 'exciting' and a 'very promising therapy' in an editorial published in Neuro-Oncology, the leading journal of the Society of Neuro-Oncology.
New research findings demonstrate that school-based dental sealant programs, in which students receive preventative oral care while at school, are cost-effective in protecting at-risk children's permanent teeth from decay.
Among mechanically ventilated intensive care unit (ICU) patients, receipt of high-protein nutrition via a feeding tube enriched with immune-modulating nutrients (such as glutamine, omega-3 fatty acids, and antioxidants) vs standard high-protein nutrition did not result in a significant difference in the incidence of new complications and may be harmful, as suggested by an increased risk of death at 6 months, according to a study in the August 6 issue of JAMA.
Survivors of a terror attack have an increased risk of frequent migraine and tension headaches after the attack, according to a study published in the December 13, 2017, online issue of Neurology®, the medical journal of the American Academy of Neurology.
› Verified 6 days ago